Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review

BackgroundIt is critical to develop a reliable and cost-effective prognostic tool for colorectal cancer (CRC) stratification and treatment optimization. Tumor–stroma ratio (TSR) may be a promising indicator of poor prognosis in CRC patients. As a result, we conducted a systematic review on the predi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jinlai Gao, Zhangguo Shen, Zaixing Deng, Lina Mei
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c4053897b2134acf916e0f8874c0b5d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4053897b2134acf916e0f8874c0b5d6
record_format dspace
spelling oai:doaj.org-article:c4053897b2134acf916e0f8874c0b5d62021-11-16T07:19:08ZImpact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review2234-943X10.3389/fonc.2021.738080https://doaj.org/article/c4053897b2134acf916e0f8874c0b5d62021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.738080/fullhttps://doaj.org/toc/2234-943XBackgroundIt is critical to develop a reliable and cost-effective prognostic tool for colorectal cancer (CRC) stratification and treatment optimization. Tumor–stroma ratio (TSR) may be a promising indicator of poor prognosis in CRC patients. As a result, we conducted a systematic review on the predictive value of TSR in CRC.MethodsThis study was carried out according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline. An electronic search was completed using commonly used databases PubMed, CENTRAL, Cochrane Central Register of Controlled Trials, and Google scholar till the last search up to May 30, 2021. STATA version 13 was used to analyze the data.ResultsA total of 13 studies [(12 for disease-free survival (DFS) and nine studies for overall survival (OS)] involving 4,857 patients met the inclusion criteria for the systematic review in the present study. In individuals with stage II CRC, stage III CRC, or mixed stage CRC, we observed a significantly higher pooled hazard ratio (HR) in those with a low TSR/greater stromal content (HR, 1.54; 95% CI: 1.20 to 1.88), (HR, 1.90; 95% CI: 1.35 to 2.45), and (HR, 1.70; 95% CI: 1.45 to 1.95), respectively, for predicting DFS. We found that a low TSR ratio had a statistically significant predictive relevance for stage II (HR, 1.43; 95% CI: 1.09 to 1.77) and mixed stages of CRC (HR, 1.65; 95% CI: 1.31 to 2.0) for outcome OS.ConclusionIn patients with CRC, low TSR was found to be a prognostic factor for a worse prognosis (DFS and OS).Jinlai GaoZhangguo ShenZaixing DengLina MeiFrontiers Media S.A.articletumor–stroma ratiocolorectal cancermeta-analysisstroma contentprognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic tumor–stroma ratio
colorectal cancer
meta-analysis
stroma content
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle tumor–stroma ratio
colorectal cancer
meta-analysis
stroma content
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Jinlai Gao
Zhangguo Shen
Zaixing Deng
Lina Mei
Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
description BackgroundIt is critical to develop a reliable and cost-effective prognostic tool for colorectal cancer (CRC) stratification and treatment optimization. Tumor–stroma ratio (TSR) may be a promising indicator of poor prognosis in CRC patients. As a result, we conducted a systematic review on the predictive value of TSR in CRC.MethodsThis study was carried out according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline. An electronic search was completed using commonly used databases PubMed, CENTRAL, Cochrane Central Register of Controlled Trials, and Google scholar till the last search up to May 30, 2021. STATA version 13 was used to analyze the data.ResultsA total of 13 studies [(12 for disease-free survival (DFS) and nine studies for overall survival (OS)] involving 4,857 patients met the inclusion criteria for the systematic review in the present study. In individuals with stage II CRC, stage III CRC, or mixed stage CRC, we observed a significantly higher pooled hazard ratio (HR) in those with a low TSR/greater stromal content (HR, 1.54; 95% CI: 1.20 to 1.88), (HR, 1.90; 95% CI: 1.35 to 2.45), and (HR, 1.70; 95% CI: 1.45 to 1.95), respectively, for predicting DFS. We found that a low TSR ratio had a statistically significant predictive relevance for stage II (HR, 1.43; 95% CI: 1.09 to 1.77) and mixed stages of CRC (HR, 1.65; 95% CI: 1.31 to 2.0) for outcome OS.ConclusionIn patients with CRC, low TSR was found to be a prognostic factor for a worse prognosis (DFS and OS).
format article
author Jinlai Gao
Zhangguo Shen
Zaixing Deng
Lina Mei
author_facet Jinlai Gao
Zhangguo Shen
Zaixing Deng
Lina Mei
author_sort Jinlai Gao
title Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
title_short Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
title_full Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
title_fullStr Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
title_full_unstemmed Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
title_sort impact of tumor–stroma ratio on the prognosis of colorectal cancer: a systematic review
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c4053897b2134acf916e0f8874c0b5d6
work_keys_str_mv AT jinlaigao impactoftumorstromaratioontheprognosisofcolorectalcancerasystematicreview
AT zhangguoshen impactoftumorstromaratioontheprognosisofcolorectalcancerasystematicreview
AT zaixingdeng impactoftumorstromaratioontheprognosisofcolorectalcancerasystematicreview
AT linamei impactoftumorstromaratioontheprognosisofcolorectalcancerasystematicreview
_version_ 1718426631766278144